Janus Henderson Group
DNLI icon

Janus Henderson Group’s Denali Therapeutics DNLI Stock Holding History

Janus Henderson Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Hold
60,028
– – ﹤0.01% 1634
2025
Q4 		$991K Hold
60,028
– – ﹤0.01% 1677
2025
Q3 		$872K Hold
60,028
– – ﹤0.01% 1735
2025
Q2 		$839K Hold
60,028
– – ﹤0.01% 1697
2025
Q1 		$888K Hold
60,028
– – ﹤0.01% 1676
2024
Q4 		$1.22M Buy
60,028
+7,900
+15% +$202K ﹤0.01% 1585
2024
Q3 		$1.52M Hold
52,128
– – ﹤0.01% 1448
2024
Q2 		$1.21M Sell
52,128
-590
-1% -$11.3K ﹤0.01% 1522
2024
Q1 		$1.08M Buy
52,718
+26
+0% +$489 ﹤0.01% 1603
2023
Q4 		$1.13M Sell
52,692
-75
-0.1% -$1.49K ﹤0.01% 1558
2023
Q3 		$1.09M Buy
52,767
+13
+0% +$330 ﹤0.01% 1518
2023
Q2 		$1.55M Buy
52,754
+10,586
+25% +$298K ﹤0.01% 1369
2023
Q1 		$972K Buy
42,168
+26,279
+165% +$723K ﹤0.01% 1648
2022
Q4 		$442K Sell
15,889
-1
-0% -$30 ﹤0.01% 1772
2022
Q3 		$488K Sell
15,890
-178
-1% -$5.79K ﹤0.01% 1600
2022
Q2 		$472K Sell
16,068
-67,627
-81% -$1.77M ﹤0.01% 1804
2022
Q1 		$2.69M Sell
83,695
-16,768
-17% -$577K ﹤0.01% 1148
2021
Q4 		$4.48M Buy
100,463
+92,593
+1,177% +$4.39M ﹤0.01% 1091
2021
Q3 		$397K Buy
+7,870
New +$444K ﹤0.01% 1729
2018
Q1 		– Sell
-28,125
Closed -$440K – 1367
2017
Q4 		$440K Buy
+28,125
New +$505K ﹤0.01% 1234

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group's DNLI Position: Q1 2026 in Review

Janus Henderson Group held its Denali Therapeutics (DNLI) position steady in Q1 2026 at 60,028 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Janus Henderson Group first reported a position in DNLI in Q4 2017 and has held it in 20 quarters since. The position peaked at $4.48M in Q4 2021. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Janus Henderson Group held 60,028 shares of Denali Therapeutics worth $1.15M as of Q1 2026.
  • Janus Henderson Group left its Denali Therapeutics share count unchanged in Q1 2026.
  • Denali Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1634 holding.
  • Janus Henderson Group first reported a position in Denali Therapeutics in Q4 2017 and has held it in 20 quarters since.
  • Janus Henderson Group's Denali Therapeutics position peaked at $4.48M in Q4 2021.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.